Key result
The abstract text is unavailable to determine the quantitative findings regarding the probable linkage between essential familial hypercholesterolemia and the third complement component.
Observational
Does not support clinical genetic testing; leaves open validation of C3 linkage in familial hypercholesterolemia.
Research Articles| May 06 2008 Probable linkage between essential familial hypercholesterolemia and third complement component (C3) Subject Area: Genetics R.C. Elston; R.C. Elston aDepartment of Biostatistics and bGenetics Curriculum, University of North Carolina, Chapel Hill, N.C., Search for other works by this author on: This Site PubMed Google Scholar K.K. Namboodiri; K.K. Namboodiri aDepartment of Biostatistics and Search for other works by this author on: This Site PubMed Google Scholar R.C.P. Go; R.C.P. Go aDepartment of Biostatistics and Search for other works by this author on: This Site PubMed Google Scholar R.M. Siervogel; R.M. Siervogel aDepartment of Biostatistics and cFels Research Institute, Yellow Springs, Ohio, and Search for other works by this author on: This Site PubMed Google Scholar C.J. Glueck C.J. Glueck dGeneral Clinical Research Center, Cincinnati General Hospital, Cincinnati, Ohio Search for other works by this author on: This Site PubMed Google Scholar Cytogenetics and Cell Genetics (1976) 16 (1-5): 294–297. https://doi.org/10.1159/000130613 Article history Published Online: May 06 2008 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation R.C. Elston, K.K. Namboodiri, R.C.P. Go, R.M. Siervogel, C.J. Glueck; Probable linkage between essential familial hypercholesterolemia and third complement component (C3). Cytogenetics and Cell Genetics 31 December 1976; 16 (1-5): 294–297. https://doi.org/10.1159/000130613 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsCytogenetic and Genome Research Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. 1976Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
Elston et al. (2008) conducted an observational in Essential familial hypercholesterolemia. Third complement component (C3) was evaluated. The abstract text is unavailable to determine the quantitative findings regarding the probable linkage between essential familial hypercholesterolemia and the third complement component.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: